ClinicalTrials.govpublic full text
Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects
multiple sclerosis, demyelination, relapse rate, pegylated interferon beta-1a, side effects, flu-like symptoms, injection site reactions, prednisone, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856205
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.